The Retinal Imaging Biomarkers and Endpoints Summit is dedicated to ophthalmic drug development with a focus on imaging-based approaches to determine retinal function and optimize development of regulatory accepted endpoints.
The Retinal Imaging Biomarkers and Endpoints Summit covers topics such as:
- AI technology capabilities to drive retinal drug development
- Novel technologies in the retinal imaging biomarker space
- Regulatory endpoints to achieve validation & approval of sophisticated retinal imaging technologies
- Retinal imaging techniques for developing biomarkers of disease progression & drug efficacy
- Preclinical retinal imaging strategies to enhance translational capabilities
- Additional methods to optimize image-derived data & enhance retina visualization
The Retinal Imaging Biomarkers and Endpoints Summit brings together biotech and pharma scientists.
